Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT 2A receptors. O...
Saved in:
Published in | Psychopharmacology Vol. 239; no. 6; pp. 1679 - 1687 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.06.2022
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rationale
Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT
2A
receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT
2A
receptors.
Objectives
The aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT
2A
receptors in those effects.
Methods
Male mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT
2A
receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.
Results
Treatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.
Conclusions
Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT
2A
receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT
2A
receptor agonists as adjunctive pharmacotherapies for the treatment of AUD. |
---|---|
AbstractList | Abstract RationaleAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT2A receptors.ObjectivesThe aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT2A receptors in those effects.MethodsMale mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.ResultsTreatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.ConclusionsTreatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD. Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT 2A receptors. Objectives The aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT 2A receptors in those effects. Methods Male mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT 2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions. Results Treatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration. Conclusions Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT 2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT 2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD. RATIONALEAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT2A receptors.OBJECTIVESThe aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT2A receptors in those effects.METHODSMale mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.RESULTSTreatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.CONCLUSIONSTreatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD. |
Author | Barros-Santos, Thaísa Barbosa, Paulo C. R. Marinho, Eduardo A. V. de Jesus, Nailton M. S. Serra, Yasmim A. Coimbra, João P. S. A. Santana, Maria C. E. Sulima, Agnieszka Malpezzi-Marinho, Elena L. A. Rice, Kenner C. Jovita-Farias, Caio Oliveira-Lima, Alexandre J. Leite, João P. C. Anjos-Santos, Alexia Kisaki, Natali D. Berro, Laís F. |
AuthorAffiliation | 1 Department of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil 2 Department of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil 4 Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216, USA 3 Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA |
AuthorAffiliation_xml | – name: 4 Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216, USA – name: 1 Department of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil – name: 2 Department of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil – name: 3 Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA |
Author_xml | – sequence: 1 givenname: Yasmim A. surname: Serra fullname: Serra, Yasmim A. organization: Department of Health Sciences, Universidade Estadual de Santa Cruz – sequence: 2 givenname: Thaísa surname: Barros-Santos fullname: Barros-Santos, Thaísa organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 3 givenname: Alexia surname: Anjos-Santos fullname: Anjos-Santos, Alexia organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism – sequence: 4 givenname: Natali D. surname: Kisaki fullname: Kisaki, Natali D. organization: Department of Health Sciences, Universidade Estadual de Santa Cruz – sequence: 5 givenname: Caio surname: Jovita-Farias fullname: Jovita-Farias, Caio organization: Department of Health Sciences, Universidade Estadual de Santa Cruz – sequence: 6 givenname: João P. C. surname: Leite fullname: Leite, João P. C. organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 7 givenname: Maria C. E. surname: Santana fullname: Santana, Maria C. E. organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 8 givenname: João P. S. A. surname: Coimbra fullname: Coimbra, João P. S. A. organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 9 givenname: Nailton M. S. surname: de Jesus fullname: de Jesus, Nailton M. S. organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 10 givenname: Agnieszka surname: Sulima fullname: Sulima, Agnieszka organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism – sequence: 11 givenname: Paulo C. R. surname: Barbosa fullname: Barbosa, Paulo C. R. organization: Department of Health Sciences, Universidade Estadual de Santa Cruz – sequence: 12 givenname: Elena L. A. surname: Malpezzi-Marinho fullname: Malpezzi-Marinho, Elena L. A. organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz – sequence: 13 givenname: Kenner C. surname: Rice fullname: Rice, Kenner C. organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism – sequence: 14 givenname: Alexandre J. surname: Oliveira-Lima fullname: Oliveira-Lima, Alexandre J. organization: Department of Health Sciences, Universidade Estadual de Santa Cruz – sequence: 15 givenname: Laís F. orcidid: 0000-0003-4841-4117 surname: Berro fullname: Berro, Laís F. email: lberro@umc.edu organization: Department of Health Sciences, Universidade Estadual de Santa Cruz, Department of Psychiatry and Human Behavior, Center for Innovation and Discovery in Addictions, University of Mississippi Medical Center – sequence: 16 givenname: Eduardo A. V. surname: Marinho fullname: Marinho, Eduardo A. V. email: eavmarinho@uesc.br organization: Department of Health Sciences, Universidade Estadual de Santa Cruz |
BookMark | eNp9kU9v1DAQxS1URLeFL8DJEhcuhvGfJM4JVRVQpEpIqJwtrzPZuErsxXZY9cwXx8tWIDjgi-V5v3kz1rsgZyEGJOQlhzccoHubAQSXDIRg0HJQ7PCEbLiSggnoxBnZAEjJJG_0ObnI-R7qUVo9I-eyEY2Ett-QH1_ijDSOtGE3d-KKJnS4LzFl6gMtE1IcR3QlHxH7YKfVZmdpDBTLZEOcacZ5ZHZYfPC5JFt81dbsw45aWg6RbWMpdYKbondI9zbZwe-Wo_tia32p1efk6WjnjC8e70vy9cP7u-sbdvv546frq1vmFOjC2rYZdSeElV2PWxzF8cW3YpBSK6mkdY1rR664rjoX3YCt662CUaMeehjkJXl38t2v2wUHh6EuPJt98otNDyZab_5Wgp_MLn43HLoGlJDV4fWjQ4rfVszFLD47nGcbMK7ZiFa2uu0VqIq--ge9j2sK9X-V6oSWfd93lRInyqWYc8Lx9zYczDFkcwrZ1JDNr5DNoTbJU1OucNhh-mP9n66fNpCrew |
CitedBy_id | crossref_primary_10_3390_plants12132573 crossref_primary_10_1007_s00213_023_06460_1 crossref_primary_10_1038_s41386_023_01666_5 crossref_primary_10_1016_j_ynstr_2024_100618 crossref_primary_10_3389_fphar_2022_1074633 crossref_primary_10_1007_s00702_024_02757_3 crossref_primary_10_1007_s00213_022_06152_2 crossref_primary_10_1016_j_pnpbp_2023_110738 crossref_primary_10_1021_acschemneuro_2c00718 crossref_primary_10_3390_psychoactives3010007 crossref_primary_10_1097_JCP_0000000000001872 crossref_primary_10_1007_s40429_024_00581_z crossref_primary_10_3390_ijms24021329 |
Cites_doi | 10.1177/0269881114565144 10.1124/pr.114.009514 10.1097/FBP.0000000000000628 10.1016/S0014-2999(99)00125-9 10.1007/s00213-009-1468-9 10.2174/15733998113099990003 10.1016/j.comppsych.2016.09.003 10.3389/fphar.2018.00561 10.2174/15733998113099990002 10.1126/sciadv.aax4043 10.1016/S0376-8716(99)00148-9 10.1016/j.pharmthera.2004.03.002 10.1001/jamapsychiatry.2015.0584 10.1016/j.alcohol.2019.10.005 10.3389/fpsyt.2018.00136 10.2174/1570159X16666180125095902 10.1080/02791072.2013.873157 10.1111/dar.12985 10.1007/s00213-020-05609-6 10.1111/j.1530-0277.2010.01261.x 10.1021/cn300072u 10.1016/j.beproc.2017.04.019 10.1111/j.1360-0443.2012.04054.x 10.1037/a0014592 10.1111/dar.13348 10.1016/j.physbeh.2015.01.032 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. |
DBID | AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1007/s00213-022-06104-w |
DatabaseName | CrossRef ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts ProQuest Nursing and Allied Health Journals Neurosciences Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database (ProQuest) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Chemoreception Abstracts ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 1687 |
ExternalDocumentID | 10_1007_s00213_022_06104_w |
GrantInformation_xml | – fundername: National Institute on Drug Abuse funderid: http://dx.doi.org/10.13039/100000026 – fundername: Conselho Nacional de Desenvolvimento Científico e Tecnológico funderid: http://dx.doi.org/10.13039/501100003593 – fundername: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior funderid: http://dx.doi.org/10.13039/501100002322 – fundername: Fundação de Amparo à Pesquisa do Estado da Bahia funderid: http://dx.doi.org/10.13039/501100006181 – fundername: National Institute on Alcohol Abuse and Alcoholism funderid: http://dx.doi.org/10.13039/100000027 |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS KOW N2Q R9- RHV SBY SOJ X7M ~EX AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U --- -56 -5G -EM -~C .86 .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 203 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2QV 2~H 30V 36B 4.4 406 408 409 5RE 5VS 67N 67Z 6NX 78A 7X8 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. B0M BA0 BGNMA BKEYQ BMSDO BPHCQ BVXVI CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DXH EAD EAP EBC EBD EBLON EBS EIHBH EIOEI EMB EMK EMOBN EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- MK0 N9A NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P PF- PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RIG ROL RPX RRX RSV S16 S27 S3A S3B SAP SBL SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD SV3 SZN T13 TN5 TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX VC2 W23 W48 WH7 WIP WJK WK8 WOW YLTOR Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZMTXR ZOVNA ~8M 5PM |
ID | FETCH-LOGICAL-c408t-665f8722a379ebef2f8721b2d3384343ac5c6f141879e127de6c9a40f8e8d90d3 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 |
IngestDate | Wed Dec 27 05:21:39 EST 2023 Sat Oct 26 01:23:02 EDT 2024 Thu Oct 10 15:56:31 EDT 2024 Fri Aug 23 01:56:21 EDT 2024 Wed Oct 12 11:22:09 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Self-administration Mice Ethanol Serotonin 5-HT Ayahuasca |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c408t-665f8722a379ebef2f8721b2d3384343ac5c6f141879e127de6c9a40f8e8d90d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4841-4117 |
PMID | 35253069 |
PQID | 2672839997 |
PQPubID | 47309 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10750423 proquest_miscellaneous_2636869404 proquest_journals_2672839997 crossref_primary_10_1007_s00213_022_06104_w springer_journals_10_1007_s00213_022_06104_w |
PublicationCentury | 2000 |
PublicationDate | 2022-06-01 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Heidelberg |
PublicationTitle | Psychopharmacology |
PublicationTitleAbbrev | Psychopharmacology |
PublicationYear | 2022 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Grant, Goldstein, Saha, Chou, Jung, Zhang, Pickering, Ruan, Smith, Huang, Hasin (CR12) 2015; 72 Nolli, de Oliveira, Alves, von Zuben, Pic-Taylor, Mortari, Caldas (CR21) 2020; 84 Argento, Capler, Thomas, Lucas, Tupper (CR1) 2019; 38 Reis, Rodrigues, Anjos-Santos, Libarino-Santos, Serra, Cata-Preta, Oliveira-Campos, Kisaki, Barros-Santos, Yokoyama, Cruz, Oliveira-Lima, Barbosa, Berro, Marinho (CR24) 2020; 237 Maurel, De Vry, Schreiber (CR18) 1999; 370 Berquist, Fantegrossi (CR4) 2021; 32 Maisel, Blodgett, Wilbourne, Humphreys, Finney (CR17) 2013; 108 Bogenschutz, Forcehimes, Pommy, Wilcox, Barbosa, Strassman (CR6) 2015; 29 Cunningham, Anastasio, Fox, Stutz, Bubar, Swinford, Watson, Gilbertson, Rice, Rosenzweig-Lipson, Moeller (CR9) 2013; 4 Barbosa, Tófoli, Bogenschutz, Hoy, Berro, Marinho, Areco, Winkelman (CR3) 2018; 9 Howell, Cunningham (CR14) 2015; 67 Bogenschutz (CR5) 2013; 6 Witkiewitz, Litten, Leggio (CR27) 2019; 5 Loizaga-Velder, Verres (CR16) 2014; 46 CR28 McKenna (CR19) 2004; 102 Thomas, Lucas, Capler, Tupper, Martin (CR25) 2013; 6 CR23 CR22 Glennon, Dukat, Grella, Hong, Costantino, Teitler, Smith, Egan, Davis, Mattson (CR11) 2000; 60 Ding, Toalston, Oster, McBride, Rodd (CR10) 2009; 204 Hamill, Hallak, Dursun, Baker (CR13) 2019; 17 Cata-Preta, Serra, Moreira-Junior, Reis, Kisaki, Libarino-Santos, Silva, Barros-Santos, Santos, Barbosa, Costa, Oliveira-Lima, Berro, Marinho (CR8) 2018; 9 Li, Cheng, Bian, Liu, Zhang, Ye (CR15) 2010; 34 Valyear, Villaruel, Chaudhri (CR26) 2017; 141 Brodie, Trifunovic, Shefner (CR7) 1995; 273 Barbosa, Strassman, da Silveira, Areco, Hoy, Pommy, Thoma, Bogenschutz (CR2) 2016; 71 NicDhonnchadha, Fox, Stutz, Rice, Cunningham (CR20) 2009; 123 ZM Ding (6104_CR10) 2009; 204 MD Berquist (6104_CR4) 2021; 32 G Thomas (6104_CR25) 2013; 6 K Witkiewitz (6104_CR27) 2019; 5 BA NicDhonnchadha (6104_CR20) 2009; 123 J Li (6104_CR15) 2010; 34 NC Maisel (6104_CR17) 2013; 108 MP Bogenschutz (6104_CR6) 2015; 29 A Loizaga-Velder (6104_CR16) 2014; 46 MP Bogenschutz (6104_CR5) 2013; 6 LM Nolli (6104_CR21) 2020; 84 PCR Barbosa (6104_CR3) 2018; 9 KA Cunningham (6104_CR9) 2013; 4 LL Howell (6104_CR14) 2015; 67 BF Grant (6104_CR12) 2015; 72 E Argento (6104_CR1) 2019; 38 RA Glennon (6104_CR11) 2000; 60 6104_CR22 PC Barbosa (6104_CR2) 2016; 71 DJ McKenna (6104_CR19) 2004; 102 S Maurel (6104_CR18) 1999; 370 HS Reis (6104_CR24) 2020; 237 MS Brodie (6104_CR7) 1995; 273 EG Cata-Preta (6104_CR8) 2018; 9 MD Valyear (6104_CR26) 2017; 141 6104_CR23 J Hamill (6104_CR13) 2019; 17 6104_CR28 |
References_xml | – ident: CR22 – volume: 29 start-page: 289 issue: 3 year: 2015 end-page: 299 ident: CR6 article-title: Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study publication-title: J Psychopharmacol doi: 10.1177/0269881114565144 contributor: fullname: Strassman – volume: 273 start-page: 1139 year: 1995 end-page: 1146 ident: CR7 article-title: Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains publication-title: J Pharmacol Exp Ther contributor: fullname: Shefner – volume: 67 start-page: 176 issue: 1 year: 2015 end-page: 197 ident: CR14 article-title: Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder publication-title: Pharmacol Rev doi: 10.1124/pr.114.009514 contributor: fullname: Cunningham – volume: 32 start-page: 382 issue: 5 year: 2021 end-page: 391 ident: CR4 article-title: Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats publication-title: Behav Pharmacol doi: 10.1097/FBP.0000000000000628 contributor: fullname: Fantegrossi – volume: 370 start-page: 217 issue: 3 year: 1999 end-page: 223 ident: CR18 article-title: 5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(99)00125-9 contributor: fullname: Schreiber – volume: 204 start-page: 381 issue: 3 year: 2009 end-page: 390 ident: CR10 article-title: Involvement of local serotonin-2A but not serotonin-1B receptors in the reinforcing effects of ethanol within the posterior ventral tegmental area of female Wistar rats publication-title: Psychopharmacology doi: 10.1007/s00213-009-1468-9 contributor: fullname: Rodd – volume: 6 start-page: 30 issue: 1 year: 2013 end-page: 42 ident: CR25 article-title: Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada publication-title: Curr Drug Abuse Rev doi: 10.2174/15733998113099990003 contributor: fullname: Martin – volume: 71 start-page: 95 year: 2016 end-page: 105 ident: CR2 article-title: Psychological and neuropsychological assessment of regular hoasca users publication-title: Compr Psychiatry doi: 10.1016/j.comppsych.2016.09.003 contributor: fullname: Bogenschutz – volume: 9 start-page: 561 year: 2018 ident: CR8 article-title: Ayahuasca and its DMT- and beta-carbolines - containing ingredients block the expression of ethanol-induced conditioned place preference in mice: role of the treatment environment publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00561 contributor: fullname: Marinho – ident: CR23 – volume: 6 start-page: 17 issue: 1 year: 2013 end-page: 29 ident: CR5 article-title: Studying the effects of classic hallucinogens in the treatment of alcoholism: Rationale, methodology, and current research with psilocybin publication-title: Curr Drug Abuse Rev doi: 10.2174/15733998113099990002 contributor: fullname: Bogenschutz – volume: 5 start-page: 4043 issue: 9 year: 2019 ident: CR27 article-title: Advances in the science and treatment of alcohol use disorder publication-title: Sci Adv doi: 10.1126/sciadv.aax4043 contributor: fullname: Leggio – volume: 60 start-page: 121 issue: 2 year: 2000 end-page: 132 ident: CR11 article-title: Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(99)00148-9 contributor: fullname: Mattson – volume: 102 start-page: 111 issue: 2 year: 2004 end-page: 129 ident: CR19 article-title: Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2004.03.002 contributor: fullname: McKenna – volume: 72 start-page: 757 issue: 8 year: 2015 end-page: 766 ident: CR12 article-title: Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2015.0584 contributor: fullname: Hasin – volume: 84 start-page: 67 year: 2020 end-page: 75 ident: CR21 article-title: Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction publication-title: Alcohol doi: 10.1016/j.alcohol.2019.10.005 contributor: fullname: Caldas – volume: 9 start-page: 136 year: 2018 ident: CR3 article-title: Assessment of alcohol and tobacco use disorders among religious users of ayahuasca publication-title: Front Psychiatry doi: 10.3389/fpsyt.2018.00136 contributor: fullname: Winkelman – volume: 17 start-page: 108 issue: 2 year: 2019 end-page: 128 ident: CR13 article-title: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness publication-title: Curr Neuropharmacol doi: 10.2174/1570159X16666180125095902 contributor: fullname: Baker – volume: 46 start-page: 63 issue: 1 year: 2014 end-page: 72 ident: CR16 article-title: Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence–qualitative results publication-title: J Psychoactive Drugs doi: 10.1080/02791072.2013.873157 contributor: fullname: Verres – volume: 38 start-page: 781 issue: 7 year: 2019 end-page: 789 ident: CR1 article-title: Exploring ayahuasca-assisted therapy for addiction: a qualitative analysis of preliminary findings among an Indigenous community in Canada publication-title: Drug Alcohol Rev doi: 10.1111/dar.12985 contributor: fullname: Tupper – volume: 237 start-page: 3269 issue: 11 year: 2020 end-page: 3281 ident: CR24 article-title: Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations publication-title: Psychopharmacology doi: 10.1007/s00213-020-05609-6 contributor: fullname: Marinho – volume: 34 start-page: 1742 issue: 10 year: 2010 end-page: 1750 ident: CR15 article-title: Region-specific induction of FosB/deltaFosB by voluntary alcohol intake: effects of naltrexone publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2010.01261.x contributor: fullname: Ye – volume: 4 start-page: 110 issue: 1 year: 2013 end-page: 121 ident: CR9 article-title: Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction publication-title: ACS Chem Neurosci doi: 10.1021/cn300072u contributor: fullname: Moeller – volume: 141 start-page: 26 issue: Pt 1 year: 2017 end-page: 32 ident: CR26 article-title: Alcohol-seeking and relapse: a focus on incentive salience and contextual conditioning publication-title: Behav Processes doi: 10.1016/j.beproc.2017.04.019 contributor: fullname: Chaudhri – ident: CR28 – volume: 108 start-page: 275 issue: 2 year: 2013 end-page: 293 ident: CR17 article-title: Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04054.x contributor: fullname: Finney – volume: 123 start-page: 382 issue: 2 year: 2009 end-page: 396 ident: CR20 article-title: Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model publication-title: Behav Neurosci doi: 10.1037/a0014592 contributor: fullname: Cunningham – volume: 60 start-page: 121 issue: 2 year: 2000 ident: 6104_CR11 publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(99)00148-9 contributor: fullname: RA Glennon – volume: 102 start-page: 111 issue: 2 year: 2004 ident: 6104_CR19 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2004.03.002 contributor: fullname: DJ McKenna – volume: 6 start-page: 30 issue: 1 year: 2013 ident: 6104_CR25 publication-title: Curr Drug Abuse Rev doi: 10.2174/15733998113099990003 contributor: fullname: G Thomas – volume: 9 start-page: 136 year: 2018 ident: 6104_CR3 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2018.00136 contributor: fullname: PCR Barbosa – volume: 32 start-page: 382 issue: 5 year: 2021 ident: 6104_CR4 publication-title: Behav Pharmacol doi: 10.1097/FBP.0000000000000628 contributor: fullname: MD Berquist – volume: 34 start-page: 1742 issue: 10 year: 2010 ident: 6104_CR15 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2010.01261.x contributor: fullname: J Li – volume: 46 start-page: 63 issue: 1 year: 2014 ident: 6104_CR16 publication-title: J Psychoactive Drugs doi: 10.1080/02791072.2013.873157 contributor: fullname: A Loizaga-Velder – volume: 9 start-page: 561 year: 2018 ident: 6104_CR8 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00561 contributor: fullname: EG Cata-Preta – volume: 273 start-page: 1139 year: 1995 ident: 6104_CR7 publication-title: J Pharmacol Exp Ther contributor: fullname: MS Brodie – volume: 141 start-page: 26 issue: Pt 1 year: 2017 ident: 6104_CR26 publication-title: Behav Processes doi: 10.1016/j.beproc.2017.04.019 contributor: fullname: MD Valyear – volume: 6 start-page: 17 issue: 1 year: 2013 ident: 6104_CR5 publication-title: Curr Drug Abuse Rev doi: 10.2174/15733998113099990002 contributor: fullname: MP Bogenschutz – volume: 38 start-page: 781 issue: 7 year: 2019 ident: 6104_CR1 publication-title: Drug Alcohol Rev doi: 10.1111/dar.12985 contributor: fullname: E Argento – ident: 6104_CR23 doi: 10.1111/dar.13348 – volume: 29 start-page: 289 issue: 3 year: 2015 ident: 6104_CR6 publication-title: J Psychopharmacol doi: 10.1177/0269881114565144 contributor: fullname: MP Bogenschutz – volume: 237 start-page: 3269 issue: 11 year: 2020 ident: 6104_CR24 publication-title: Psychopharmacology doi: 10.1007/s00213-020-05609-6 contributor: fullname: HS Reis – volume: 370 start-page: 217 issue: 3 year: 1999 ident: 6104_CR18 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(99)00125-9 contributor: fullname: S Maurel – volume: 67 start-page: 176 issue: 1 year: 2015 ident: 6104_CR14 publication-title: Pharmacol Rev doi: 10.1124/pr.114.009514 contributor: fullname: LL Howell – volume: 71 start-page: 95 year: 2016 ident: 6104_CR2 publication-title: Compr Psychiatry doi: 10.1016/j.comppsych.2016.09.003 contributor: fullname: PC Barbosa – volume: 108 start-page: 275 issue: 2 year: 2013 ident: 6104_CR17 publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04054.x contributor: fullname: NC Maisel – volume: 123 start-page: 382 issue: 2 year: 2009 ident: 6104_CR20 publication-title: Behav Neurosci doi: 10.1037/a0014592 contributor: fullname: BA NicDhonnchadha – ident: 6104_CR28 – volume: 4 start-page: 110 issue: 1 year: 2013 ident: 6104_CR9 publication-title: ACS Chem Neurosci doi: 10.1021/cn300072u contributor: fullname: KA Cunningham – volume: 204 start-page: 381 issue: 3 year: 2009 ident: 6104_CR10 publication-title: Psychopharmacology doi: 10.1007/s00213-009-1468-9 contributor: fullname: ZM Ding – volume: 5 start-page: 4043 issue: 9 year: 2019 ident: 6104_CR27 publication-title: Sci Adv doi: 10.1126/sciadv.aax4043 contributor: fullname: K Witkiewitz – volume: 84 start-page: 67 year: 2020 ident: 6104_CR21 publication-title: Alcohol doi: 10.1016/j.alcohol.2019.10.005 contributor: fullname: LM Nolli – ident: 6104_CR22 doi: 10.1016/j.physbeh.2015.01.032 – volume: 72 start-page: 757 issue: 8 year: 2015 ident: 6104_CR12 publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2015.0584 contributor: fullname: BF Grant – volume: 17 start-page: 108 issue: 2 year: 2019 ident: 6104_CR13 publication-title: Curr Neuropharmacol doi: 10.2174/1570159X16666180125095902 contributor: fullname: J Hamill |
SSID | ssj0000484 ssj0068394 |
Score | 2.5038846 |
Snippet | Rationale
Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT
2A
receptor agonist... Abstract RationaleAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist... RATIONALEAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist... |
SourceID | pubmedcentral proquest crossref springer |
SourceType | Open Access Repository Aggregation Database Publisher |
StartPage | 1679 |
SubjectTerms | Agonists Alcohol Biomedical and Life Sciences Biomedicine Drinking behavior Drug self-administration Ethanol Neurosciences Original Investigation Pharmacology/Toxicology Psychedelic drugs Psychiatry Psychotropic drugs Receptor mechanisms Serotonin S2 receptors |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB1BKyEufBQQgYIGCfXCukocx3GOK9SyAhVVaCuVU2QnTrtiN6nYrFbLlT-OJx8bbYFDj0ksO5HH4-fMvDcA74PE8lhby3JpNBMiFCyxJmOmMCqJtUPYjeLN2Vc5uRCfL6PLgcfdJLv3EcnGUW-5brQbUciRUzECX7D1fdjviKf740_fv5wMDlgQ97K9kA4AtErMIfHIItURZ_7d5e7mNCDO2_mSt4KmzV50-himPaOnTUH5cbyqzXH262-Bx7t85hN41GFTHLfG9BTu2fIAHpx10fcDODpvda43I5wOtK3lCI_wfFDA3jyD39-qucWqwIhNpnyMzqvaGyrrg7MSHeLELouEmuiNvl7pZaaxKtHSj_xqjks7L5je0fVFytC_Qo31umJU_8yN4Fy383NI8uX57GpBvS_chocLd_c5XJyeTD9OWFftgWXCVzWTMipUzLkOY2cttuB0FRieu0M00V91FmWyCASVR7cBj3Mrs0QLv1BW5Ymfhy9gr6xK-xIwVDbQsTTuyK1FYJyPsibPQx4ZHQrl5x586Kc5vWlFPdKtfHMzAambgLSZgHTtwWFvCWm3wJcpl7EDZg5dxx682z52S5PiLbq01YrahFLJRPjCA7VjQdtRSdx790k5u25EvgPCcg7rejDqDWUY_f8v--puzV_DQ97aGvODQ9irf67sG4eyavO2W1V_ABz0Hs0 priority: 102 providerName: Springer Nature |
Title | Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice |
URI | https://link.springer.com/article/10.1007/s00213-022-06104-w https://www.proquest.com/docview/2672839997 https://search.proquest.com/docview/2636869404 https://pubmed.ncbi.nlm.nih.gov/PMC10750423 |
Volume | 239 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9swEBZbC2MvY-s2lq0rGoy-LGK2LEv200hGsrDREEoC2ZORLLkNJHY2J4Q874_vznZiUtiejCzZEtzp7qS7-46Qj37suNLOMSuNZkIEgsXOpMxkJoqVBgu7Qry5GcvRTHyfh_Pmwq1swioPMrES1LZI8Y78M5cKNCGYM-rL-hfDqlHoXW1KaDwm5z73JIZ0qblqJbHAJMy6IeHjGpI5wISyMGoyaKo8OtR06M7kWOjAE2x3qqVa0_Nh4OQD72mllIbPybPGmqS9mvwvyCOXX5AnN42__IJcT2pk6n2XTttEq7JLr-mkxazevyR_boulo0VGQzaa8h4FOejWWIiHLnIKNiJt4j5wiN7r-60uU02LnDq8ei-WtHTLjOkTJF6KMfV3VNPNrmBYsQxmAGELkoki4Lhd3K3w7ytQUXQFb1-R2XAw_TpiTX0Glgov2jApwyxSnOtAAX1dxrHlG27h2IsJqzoNU5n5AguaO58r62Qaa-FlkYts7NngNTnLi9y9ITSInK-VNHBI1sI3IFWcsTbgodGBiDzbIZ8O9EjWNQxHcgRcrqiXAPWSinrJrkMuDyRLmi1ZJi0DdciHYzdsJvSQ6NwVWxwTyEjGwhMdEp2Q-jgrwnGf9uSL-wqW20frC6zTDukeuKKd_d-Lffv_xb4jT3nNmMzzL8nZ5vfWvQc7aGOuKma_Iue9Yb8_xue3nz8G8OwPxpNb6J3x3l818AsC |
link.rule.ids | 230,315,783,787,888,12068,21400,27936,27937,31731,31732,33756,33757,41093,41535,42162,42604,43322,43817,52123,52246,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwED7BkIAXBAO0jAFGQnuhFonj2M4TmhBTgXWaUCf1LbJjZ6vUJmVpVfWZP44vSRt1EjwmdmJLZ9999t19B_AxSh2T2jlqhdGU85jT1JmcmsKoVGqPsBvGm9GlGF7zH5Nk0l241V1Y5VYnNoraVjnekX9mQnpL6OGM_LL4TbFqFHpXuxIaD-ER8nBhBQM5kb0m5piE2T4I_3FLyRxjQlmiugyaJo8OLR26MxkWOgg5Xe9bqR563g-cvOc9bYzS-XN41qFJctaK_wU8cOUhPB51_vJDOL1qmak3AzLuE63qATklVz1n9eYl_PlVzRypCpLQ4ZidEa8H3QIL8ZBpSTxGJF3cB3bRG3270nWuSVUSh1fv1YzUblZQvcfESzCm_oZoslxXFCuW-RG8svWaiSDhuJ3ezPHvc2-iyNy_fQXX59_GX4e0q89Acx6qJRUiKZRkTMfSy9cVDJ8iw6w_9mLCqs6TXBQRx4LmLmLSOpGnmoeFcsqmoY1fw0FZle4ISKxcpKUw_pCseWS8VnHG2pglRsdchTaAT1t5ZIuWhiPbES430su89LJGetk6gJOtyLJuS9ZZv4AC-LBr9psJPSS6dNUK-8RCiZSHPAC1J-rdqEjHvd9STm8bWu4I0ZdHpwEMtquiH_3fkz3-_2Tfw5PheHSRXXy__PkGnrJ2kdIwOoGD5d3KvfWYaGneNQv_L5rCCFY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FMpeRtdtzFu3aTD6sojasizLT6PbGrIfDaGk0DcjW3IbSOysTgh53j8-na3EpLA9yhaS4U53n3x33wF8DBLDYmUM1SJTlPOQ08RkOc2KTCaxsgi7Yby5HInhNf9xE924_KfapVVubWJjqHWV4z_yMyZi6wktnInPCpcWMf42-Lz4TbGDFEZaXTuNx3AQcxH6PTj4cjEaX3V2mWNJZjsQdqmWoDnE8rJIunqapqoO_R4GNxm2PfA5Xe_7rA6IPkyjfBBLbVzU4AieOmxJzltleAaPTHkMh5cuen4Mp-OWp3rTJ5Ou7Kruk1My7hisN8_hz1U1M6QqSESHE3ZOrFU0C2zLQ6YlsYiRuCwQnKI26m6l6lyRqiQGf8RXM1KbWUHVHi8vwQz7W6LIcl1R7F9md7Cm19opgvTjeno7x9Xn1mGRuX36Aq4HF5OvQ-q6NdCc-3JJhYgKGTOmwthK2xQMR0HGtL0EY_mqyqNcFAHH9uYmYLE2Ik8U9wtppE58Hb6EXlmV5hWQUJpAxSKzV2bFg8zaGJNpHbIoUyGXvvbg01Ye6aIl5Uh39MuN9FIrvbSRXrr24GQrstQd0Drt1MmDD7vX9mhhvESVplrhnFBIkXCfeyD3RL3bFcm599-U07uGpDtALGaxqgf9rVZ0u__7Y1___2Pfw6HV-vTX99HPN_CEtTpK_eAEesv7lXlrAdIye-c0_y-rtw3z |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+5-HT2A+receptors+in+the+effects+of+ayahuasca+on+ethanol+self-administration+using+a+two-bottle+choice+paradigm+in+male+mice&rft.jtitle=Psychopharmacology&rft.au=Serra%2C+Yasmim+A.&rft.au=Barros-Santos%2C+Tha%C3%ADsa&rft.au=Anjos-Santos%2C+Alexia&rft.au=Kisaki%2C+Natali+D.&rft.date=2022-06-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=239&rft.issue=6&rft.spage=1679&rft.epage=1687&rft_id=info:doi/10.1007%2Fs00213-022-06104-w&rft_id=info%3Apmid%2F35253069&rft.externalDBID=PMC10750423 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |